PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BTDR vs. THC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BTDR and THC is 0.10, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

BTDR vs. THC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bitdeer Technologies Group Class A Ordinary Shares (BTDR) and Tenet Healthcare Corporation (THC). The values are adjusted to include any dividend payments, if applicable.

-50.00%0.00%50.00%100.00%150.00%200.00%250.00%300.00%SeptemberOctoberNovemberDecember2025February
123.33%
-14.11%
BTDR
THC

Key characteristics

Sharpe Ratio

BTDR:

0.62

THC:

1.32

Sortino Ratio

BTDR:

1.67

THC:

2.08

Omega Ratio

BTDR:

1.19

THC:

1.26

Calmar Ratio

BTDR:

1.15

THC:

0.89

Martin Ratio

BTDR:

2.57

THC:

4.97

Ulcer Index

BTDR:

27.92%

THC:

10.33%

Daily Std Dev

BTDR:

114.79%

THC:

38.99%

Max Drawdown

BTDR:

-79.52%

THC:

-98.28%

Current Drawdown

BTDR:

-42.41%

THC:

-36.15%

Fundamentals

Market Cap

BTDR:

$3.19B

THC:

$12.70B

EPS

BTDR:

-$0.56

THC:

$32.63

Total Revenue (TTM)

BTDR:

$280.76M

THC:

$15.59B

Gross Profit (TTM)

BTDR:

$61.30M

THC:

$3.22B

EBITDA (TTM)

BTDR:

-$22.85M

THC:

$3.25B

Returns By Period

In the year-to-date period, BTDR achieves a -30.64% return, which is significantly lower than THC's 5.61% return.


BTDR

YTD

-30.64%

1M

-28.09%

6M

123.33%

1Y

116.88%

5Y*

N/A

10Y*

N/A

THC

YTD

5.61%

1M

1.87%

6M

-14.64%

1Y

46.61%

5Y*

32.09%

10Y*

11.55%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BTDR vs. THC — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BTDR
The Risk-Adjusted Performance Rank of BTDR is 7171
Overall Rank
The Sharpe Ratio Rank of BTDR is 6666
Sharpe Ratio Rank
The Sortino Ratio Rank of BTDR is 7272
Sortino Ratio Rank
The Omega Ratio Rank of BTDR is 6767
Omega Ratio Rank
The Calmar Ratio Rank of BTDR is 8080
Calmar Ratio Rank
The Martin Ratio Rank of BTDR is 6868
Martin Ratio Rank

THC
The Risk-Adjusted Performance Rank of THC is 7979
Overall Rank
The Sharpe Ratio Rank of THC is 8383
Sharpe Ratio Rank
The Sortino Ratio Rank of THC is 7979
Sortino Ratio Rank
The Omega Ratio Rank of THC is 7777
Omega Ratio Rank
The Calmar Ratio Rank of THC is 7676
Calmar Ratio Rank
The Martin Ratio Rank of THC is 8080
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BTDR vs. THC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Bitdeer Technologies Group Class A Ordinary Shares (BTDR) and Tenet Healthcare Corporation (THC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BTDR, currently valued at 0.62, compared to the broader market-2.000.002.004.000.621.33
The chart of Sortino ratio for BTDR, currently valued at 1.67, compared to the broader market-6.00-4.00-2.000.002.004.006.001.672.09
The chart of Omega ratio for BTDR, currently valued at 1.19, compared to the broader market0.501.001.502.001.191.26
The chart of Calmar ratio for BTDR, currently valued at 1.15, compared to the broader market0.002.004.006.001.151.90
The chart of Martin ratio for BTDR, currently valued at 2.57, compared to the broader market-10.000.0010.0020.0030.002.574.95
BTDR
THC

The current BTDR Sharpe Ratio is 0.62, which is lower than the THC Sharpe Ratio of 1.32. The chart below compares the historical Sharpe Ratios of BTDR and THC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.006.00SeptemberOctoberNovemberDecember2025February
0.62
1.33
BTDR
THC

Dividends

BTDR vs. THC - Dividend Comparison

Neither BTDR nor THC has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

BTDR vs. THC - Drawdown Comparison

The maximum BTDR drawdown since its inception was -79.52%, smaller than the maximum THC drawdown of -98.28%. Use the drawdown chart below to compare losses from any high point for BTDR and THC. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-42.41%
-20.89%
BTDR
THC

Volatility

BTDR vs. THC - Volatility Comparison

Bitdeer Technologies Group Class A Ordinary Shares (BTDR) has a higher volatility of 35.99% compared to Tenet Healthcare Corporation (THC) at 13.88%. This indicates that BTDR's price experiences larger fluctuations and is considered to be riskier than THC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%SeptemberOctoberNovemberDecember2025February
35.99%
13.88%
BTDR
THC

Financials

BTDR vs. THC - Financials Comparison

This section allows you to compare key financial metrics between Bitdeer Technologies Group Class A Ordinary Shares and Tenet Healthcare Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab